Advertisement

Topics

Pilot Study Testing Feasibility of Health Screening at Farm Site

2015-05-13 18:23:22 | BioPortfolio

Summary

Test the feasibility of performing worksite screening of Hypertension, Diabetes and Hyperlipidemia for six months

Description

The investigators will be visiting farmers at the worksite monthly for six month and perform cardiovascular risk factors screening: blood pressure, blood glucose, glycosylated hemoglobin and cholesterol.

At the end of this intervention, the investigators will test the feasibility of this approach among this specific population through questionnaires.

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention

Conditions

Diabetes Screening

Intervention

Worksite screening for DM, HTN and hyperlipidemia

Location

Mayo Clinic in Rochester
Rochester
Minnesota
United States
55905

Status

Recruiting

Source

Mayo Clinic

Results (where available)

View Results

Links

Published on BioPortfolio: 2015-05-13T18:23:22-0400

Clinical Trials [3716 Associated Clinical Trials listed on BioPortfolio]

Worksite Lifestyle Program for Reducing Diabetes and Cardiovascular Risk in India

This study will test the implementation, effectiveness, cost-effectiveness, and acceptability of a worksite lifestyle improvement program that includes lifestyle education classes led by t...

Randomization of Early Diabetes Screening Among Obese Pregnant Women.

This will be a randomization of two groups of obese pregnant women into early screening for diabetes mellitus at the time of their first or subsequent prenatal visits before 20 weeks of ge...

Increasing Screening for Type 2 Diabetes in Women With Previous Gestational Diabetes.

In 1998, The Canadian Diabetes Association published guidelines that recommended women diagnosed with gestational diabetes mellitus (GDM,) should be screened postpartum for Type 2 diabetes...

One Step Versus Two Step Approach for Gestational Diabetes Mellitus Screening

Our study will assess if there is a difference in incidence of gestational diabetes using different screening approaches, either using a one-step approach with a 2 hour glucose tolerance t...

Smartphone Screening for Eye Diseases

To validate new screening instruments for eye disease, increase eye care access in underserved communities, and provide a scientifically implemented method to set up programs for eye disea...

PubMed Articles [7658 Associated PubMed Articles listed on BioPortfolio]

Patient and physician predictors of hyperlipidemia screening and statin prescription.

Appropriate lipid management has been demonstrated to reduce cardiovascular events, but rates of hyperlipidemia screening and statin therapy are suboptimal. We aimed to evaluate patient and physician ...

Prevention and screening recommendations in type 2 diabetes: Review and critical appraisal of clinical practice guidelines.

The aim of this review was to identify and appraise guidelines reporting recommendations for the screening and prevention of type 2 diabetes. Five guidelines were included for analysis and all were en...

Screening of Hyperlipidemia among Patients with Rheumatoid Arthritis in the United States.

To determine the proportion of primary lipid screening among patients with rheumatoid arthritis (RA) and compare it with patients with diabetes mellitus (DM) and patients with neither RA nor DM. To de...

Diabetes screening among active TB patients in WA TB control program using HbA1c.

Diabetes mellitus is an important risk factor for tuberculosis and studies in high tuberculosis burden countries have shown diabetes screening to be both feasible and to have a high yield. However, sc...

Fasting Glycemia as Screening Tool to Rule-Out Gestational Diabetes in Low-Risk Population.

The use of a glucose challenge test as the universal screening for gestational diabetes is common in many countries. This test represents significant costs for laboratories and inconveniences for the ...

Medical and Biotech [MESH] Definitions

The identification of selected parameters in newborn infants by various tests, examinations, or other procedures. Screening may be performed by clinical or laboratory measures. A screening test is designed to sort out healthy neonates (INFANT, NEWBORN) from those not well, but the screening test is not intended as a diagnostic device, rather instead as epidemiologic.

Testing or screening required by federal, state, or local law or other agencies for the diagnosis of specified conditions. It is usually limited to specific populations such as categories of health care providers, members of the military, and prisoners or to specific situations such as premarital examinations or donor screening.

Examination of urine by chemical, physical, or microscopic means. Routine urinalysis usually includes performing chemical screening tests, determining specific gravity, observing any unusual color or odor, screening for bacteriuria, and examining the sediment microscopically.

Measures for assessing the results of diagnostic and screening tests. Sensitivity represents the proportion of truly diseased persons in a screened population who are identified as being diseased by the test. It is a measure of the probability of correctly diagnosing a condition. Specificity is the proportion of truly nondiseased persons who are so identified by the screening test. It is a measure of the probability of correctly identifying a nondiseased person. (From Last, Dictionary of Epidemiology, 2d ed)

Identification of individuals who are heterozygous at a GENETIC LOCUS for a recessive PHENOTYPE.

More From BioPortfolio on "Pilot Study Testing Feasibility of Health Screening at Farm Site"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Nephrology - kidney function
Nephrology is a specialty of medicine and pediatrics that concerns itself with the study of normal kidney function, kidney problems, the treatment of kidney problems and renal replacement therapy (dialysis and kidney transplantation). Systemic conditions...


Searches Linking to this Trial